Intravenous Infusion Pumps Market Size, Share & Trends Report

Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report By Product (Volumetric Infusion Pumps, Syringe Infusion Pumps), By Disease Indication (Chemotherapy, Diabetes, Gastroenterology), By Region, And Segment Forecasts, 2025 - 2030

Report ID: GVR-4-68038-560-1
Number of Report Pages: 100
Format: PDF

Historical Range: 2018 - 2023
Forecast Period: 2025 - 2030
Industry: Healthcare

Market Segmentation

Intravenous Infusion Pumps Product Outlook (Revenue, USD Million, 2018 - 2030)
- Volumetric infusion pumps
- Syringe infusion pumps
- Insulin infusion pumps
- Enteral infusion pumps
- Ambulatory infusion pumps
- Patient-controlled analgesia infusion pumps
- Implantable infusion pumps
- Others
Intravenous Infusion Pumps Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Chemotherapy
- Diabetes
- Gastroenterology
- Analgesia/pain management
- Pediatrics/neonatology
- Hematology
- Others
Intravenous Infusion Pumps Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Volumetric infusion pumps
    - Syringe infusion pumps
    - Insulin infusion pumps
    - Enteral infusion pumps
    - Ambulatory infusion pumps
    - Patient-controlled analgesia infusion pumps
    - Implantable infusion pumps
    - Others
  - North America Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
    - Chemotherapy
    - Diabetes
    - Gastroenterology
    - Analgesia/Pain management
    - Pediatrics/Neonatology
    - Hematology
    - Others
  - U.S.
    - U.S. Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - U.S. Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Canada
    - Canada Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Canada Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Mexico
    - Mexico Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Mexico Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
- Europe
  - Europe Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Volumetric infusion pumps
    - Syringe infusion pumps
    - Insulin infusion pumps
    - Enteral infusion pumps
    - Ambulatory infusion pumps
    - Patient-controlled analgesia infusion pumps
    - Implantable infusion pumps
    - Others
  - Europe Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
    - Chemotherapy
    - Diabetes
    - Gastroenterology
    - Analgesia/Pain management
    - Pediatrics/Neonatology
    - Hematology
    - Others
  - UK
    - UK Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - UK Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Germany
    - Germany Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Germany Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - France
    - France Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - France Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Italy
    - Italy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Italy Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Spain
    - Spain Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Spain Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Denmark
    - Denmark Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Denmark Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Sweden
    - Sweden Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Sweden Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Norway
    - Norway Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Norway Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
- Asia Pacific
  - Asia Pacific Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Volumetric infusion pumps
    - Syringe infusion pumps
    - Insulin infusion pumps
    - Enteral infusion pumps
    - Ambulatory infusion pumps
    - Patient-controlled analgesia infusion pumps
    - Implantable infusion pumps
    - Others
  - Asia Pacific Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
    - Chemotherapy
    - Diabetes
    - Gastroenterology
    - Analgesia/Pain management
    - Pediatrics/Neonatology
    - Hematology
    - Others
  - China
    - China Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - China Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Japan
    - Japan Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Japan Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - India
    - India Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - India Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Australia
    - Australia Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Australia Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - South Korea
    - South Korea Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - South Korea Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Thailand
    - Thailand Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Thailand Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
- Latin America
  - Latin America Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Volumetric infusion pumps
    - Syringe infusion pumps
    - Insulin infusion pumps
    - Enteral infusion pumps
    - Ambulatory infusion pumps
    - Patient-controlled analgesia infusion pumps
    - Implantable infusion pumps
    - Others
  - Latin America Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
    - Chemotherapy
    - Diabetes
    - Gastroenterology
    - Analgesia/Pain management
    - Pediatrics/Neonatology
    - Hematology
    - Others
  - Brazil
    - Brazil Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Brazil Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Argentina
    - Argentina Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Argentina Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
- Middle East & Africa
  - Middle East & Africa Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Volumetric infusion pumps
    - Syringe infusion pumps
    - Insulin infusion pumps
    - Enteral infusion pumps
    - Ambulatory infusion pumps
    - Patient-controlled analgesia infusion pumps
    - Implantable infusion pumps
    - Others
  - Middle East & Africa Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
    - Chemotherapy
    - Diabetes
    - Gastroenterology
    - Analgesia/Pain management
    - Pediatrics/Neonatology
    - Hematology
    - Others
  - South Africa
    - South Africa Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - South Africa Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Saudi Arabia
    - Saudi Arabia Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Saudi Arabia Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - UAE
    - UAE Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - UAE Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others
  - Kuwait
    - Kuwait Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Volumetric infusion pumps
      - Syringe infusion pumps
      - Insulin infusion pumps
      - Enteral infusion pumps
      - Ambulatory infusion pumps
      - Patient-controlled analgesia infusion pumps
      - Implantable infusion pumps
      - Others
    - Kuwait Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Chemotherapy
      - Diabetes
      - Gastroenterology
      - Analgesia/Pain management
      - Pediatrics/Neonatology
      - Hematology
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.